Aerie Pharmaceuticals (AERI) News Today → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free AERI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline20 Countries With Worst Vision Problemsuk.finance.yahoo.com - February 29 at 8:07 AMParatus Sciences Appoints Theresa Heah, M.D., M.B.A. as Chief Executive Officerfinance.yahoo.com - February 21 at 8:44 AMJustin Timberlake is ready to Rock Your Body for one night only in Memphis, and for freemsn.com - January 12 at 11:47 PMAlcon’s dry eye drug achieves primary endpoints in Phase III trialsmsn.com - January 10 at 1:48 PMCurative Biotechnology, Inc.: Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directorsfinanznachrichten.de - January 8 at 1:56 PMCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directorsmarkets.businessinsider.com - January 8 at 1:56 PMGlaucoma Therapeutics Market Size Projected to Reach USD 13.5 billion by 2031, With 5.5% CAGR: Transparency Market Research, Inc.finance.yahoo.com - December 15 at 11:31 AMGlobal Over the Counter (OTC) Drugs Market Size to Grow USD 265 Billion by 2032 | CAGR of 5.0%finance.yahoo.com - November 28 at 8:46 AMAerie’s Black Friday Sale is here —Save 40% off sitewide for a limited timenypost.com - November 25 at 12:41 PMNetarsudil for Fuchs Endothelial Corneal Dystrophy (FECD), 2019-2023 Emerging Drug Insights and Forecasts to 2032finance.yahoo.com - November 23 at 12:49 PMGlobal Glaucoma Treatment Market Size To Grow USD 10.5 Billion by 2032 | CAGR of 5.0%finance.yahoo.com - November 23 at 7:49 AMOpthea Limited: Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFOfinanznachrichten.de - October 27 at 7:43 AMOpthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFOmarkets.businessinsider.com - October 27 at 7:43 AMRetinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsightfinance.yahoo.com - October 23 at 1:15 PMRising Glaucoma Cases Forecast a Strong Optic Nerves Disorder Treatment Marketuk.finance.yahoo.com - September 25 at 8:34 AMOptic Nerves Disorder Treatment Market Rises: North America Takes the Helmbenzinga.com - September 13 at 10:03 PMAerie Promo Codestime.com - August 25 at 3:28 PMAngina Pectoris Drugs Global Market Report 2023uk.finance.yahoo.com - August 24 at 6:39 PMOcular Hypertension Treatment Global Market Report 2023uk.finance.yahoo.com - August 24 at 6:39 PMAlcon (ALC) Gains From Robust Contact Lense Sales, Launchesmsn.com - July 18 at 2:32 PMVillageMD Welcomes Richard Rubino as Chief Financial Officerfinance.yahoo.com - June 27 at 12:38 PMThe Glaucoma Therapeutics market's size, share, and revenue will be thoroughly examined, with an anticipated CAGR of 13% increase from 2023 to 2030.marketwatch.com - June 22 at 7:09 PMI-Mab Announces the Appointment of Raj Kannan as CEOuk.finance.yahoo.com - June 22 at 8:59 AMI-Mab Names Raj Kannan CEO - Quick Factsmarkets.businessinsider.com - June 22 at 8:59 AMOphthalmic Drugs Global Market Report 2023uk.finance.yahoo.com - June 8 at 10:48 AMAlcon (ALC) Vision Care Sales Robust, Margin Pressure Persistsmsn.com - May 17 at 12:17 PMGlaucoma Therapeutics Market Size and Growth Analysis 2023-2031 by Absolute Reports with [121 Pages] in Pharmaceuticals Sectormarketwatch.com - May 17 at 12:17 PMOptic Nerves Disorder Treatment Market Size Fundamentals And Forecast Analysis 2023-2030marketwatch.com - May 17 at 7:17 AMOphthalmology Therapeutics Market 2023: Global Opportunity Analysis by Revenue, Gross Margin, Market Sharemarketwatch.com - May 16 at 9:16 PM2030 Vision: Ophthalmology Drugs Market Value to Hit New Heightsmarketwatch.com - May 5 at 11:48 PMAnophthalmia and Microphthalmia Treatment Market Share, Size and Value Analysis with growing 5.3% CAGR during period 2023 to 2030marketwatch.com - May 5 at 1:47 PMGlaucoma Therapeutics Market Trend Analysis, Future Demand, Updates (2023-2030)marketwatch.com - May 4 at 5:44 PMRho Kinases Inhibitor Market 2023 Precise Outlook – Kowa Pharmaceuticals, Senju Pharmaceutical, Novartis AG, AERIE PHARMACEUTICALSmarketwatch.com - May 4 at 12:44 PMMindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategyuk.news.yahoo.com - May 2 at 9:29 AMGlaucoma Treatment Market Upcoming Trends, Size, Key Players, Revenue, Share, and Forecast 2023 to 2031marketwatch.com - May 2 at 9:29 AMWave-Front Aberrometer Market Research 2023 Growth, Trends, Outlook and Future Scope Analysis 2031marketwatch.com - April 28 at 10:41 PMGlaucoma and Dry Eye Diseases Market Research Analysis 2023-2031marketwatch.com - April 27 at 4:07 PM2023 to 2030, Rho Associated Protein Kinase 2 Market Demandmarketwatch.com - April 27 at 11:07 AMAerie Pharma Falls on Glaucoma Eye Drop Safety Concernsthestreet.com - April 26 at 8:19 AMCAGR of 7.7% | Global Fuchs Endothelial Corneal Dystrophy Market Size To Grow USD 360 Billion By 2032finance.yahoo.com - April 20 at 3:01 PMGlobal Glaucoma Therapeutics Market to Reach $7.2 Billion by 2030finance.yahoo.com - April 14 at 10:37 AMOphthalmology Therapeutics Market Data Source, And Forecast 2030marketwatch.com - April 13 at 6:57 PM2023 Rho Associated Protein Kinase 2 Market Share and Latest Growth Demand Status: Trends Analysis and Industry Expansion Strategiesmarketwatch.com - April 7 at 8:05 PMRho Associated Protein Kinase 2 Market Growth Predictions and Forecast 2030marketwatch.com - April 5 at 3:08 PMROCK2 Inhibitor Market 2023-2028: Future Updatesmarketwatch.com - March 28 at 2:22 PMGlobal Nystagmus Market Size by Application (Hospitals & Clinics, Research Centers) Forecast from 2023 to 2028marketwatch.com - March 27 at 1:02 PMRho-kinase Inhibitor Drugs Market Hitting New Highs by 2029 | Kowa Pharmaceuticals, Senju Pharmaceutical, Novartismarketwatch.com - March 27 at 1:02 PMRho Associated Protein Kinase 2 Market by 2031marketwatch.com - March 27 at 8:02 AMOphthalmic Therapeutic Drugs Market Statistics [2023-2028]: Emerging Trends and Future Growth Scenariomarketwatch.com - March 21 at 10:02 AMOphthalmology Drugs Market Insights and Forecast to 2028marketwatch.com - March 20 at 8:41 AM Get Aerie Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon’s New A.I. Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. AERI Media Mentions By Week AERI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AERI News Sentiment▼0.000.34▲Average Medical News Sentiment AERI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AERI Articles This Week▼00▲AERI Articles Average Week Get Aerie Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRGX News Today RLAY News Today RGNX News Today CGEM News Today MESO News Today KYTX News Today CABA News Today HLVX News Today IMTX News Today BCRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AERI) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsIs Tesla going out of business?DTIThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerie Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
